About 5.6 MYL shares traded (equal to 25-day moving avg), making it the 2nd most active stock across US exchanges ** MYL sharply cuts YTD gains to 6.5 pct, below S&P 500 health sector's ~8 pct rise; ABT up 16.4 pct
Mylan
GuruFocus gives the stock a profitability and growth rating of 8 out of 10 ... The guru purchased 1,010,598 shares of Abbott Laboratories ( ABT) with an impact of 0.5% on the portfolio. The company discovers, develops, manufactures and sells …
Joel Greenblatt
This top pharmaceutical stock has very solid growth potential and income. Abbott Laboratories (NYSE: ABT) is a leading diversified global health care company that develops, manufactures and markets branded generics, medical devices, …
Merrill Lynch
Linked here is a detailed quantitative analysis of Abbott Laboratories (ABT). Below are some highlights from the above linked analysis: Company Description: Abbott Laboratories is a diversified life science company that is planning to split …
Real-World Data from Abbott's FreeStyle® Libre Show Association Between Higher Frequency of Glucose Monitoring and Improved Glucose Control for People with Diabetes Abbott Laboratories Gains Despite Unimpressive Q4 Revenue …
After completing a $5 billion buyback program started late 2008, Abbott Laboratories (NYSE:ABT) is ready to buy another $3 billion worth of Abbott Laboratories stock. Abbott Laboratories (NYSE:ABT) seems to think its stock is cheap …
Finally, Jefferies Group boosted their price target on Abbott Laboratories from $49.00 to $52.00 and gave the company a "buy" rating in a research report on Thursday, August 4th. The company has its Price to Sales (P/S) ratio of 2.87 where …
Abbott Laboratories (NYSE:ABT) stock is down almost 8% since the end of May. Is now a good time to buy? Let's take a look. What happened? Although the company announced first-quarter results just days before the decline, those results …
The Motley Fool
Abbott Laboratories's (ABT) is a part of Healthcare sector and belongs to Medical Appliances & Equipment industry. Stock performance in last five sessions is recorded as 11.63% while year to date (YTD) performance is -73.97%. Abbott …
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. It operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular …
Abbott Laboratories